Popular Articles

JCR And The Joint Commission To Host Pediatric Safety Conference
Children are especially vulnerable in the hospital and they are the population at highest risk of a medication error, according to the American Academy of Pediatrics. Meeting their needs in this environment can be especially challenging. The Joint Commission and Joint Commission Res (JCR) "Pediatric Conference: Safe Care, Quality Care, We Care" will help health care organizations review current pediatric emergency and perioperative services as benchmarks to improve their organizational approaches. JCR is a not-for-profit affiliate of The Joint Commission.
drugs without prescription
To Maintain Normal Daily Function, Those With Insomnia Need Increased Brain Activation
According to a research abstract presented at SLEEP 2009, the 23rd Annual Meeting of the Associated Professional Sleep Societies, patients suffering from chronic primary insomnia (PIs) have higher levels of brain activation compared to normal sleepers during a working memory test.
News of the day
Exelixis Reports Encouraging Phase 1 Data To Be Presented At ASCO For XL228, A Multi-Targeted Inhibitor Of Key Cancer Signaling Kinases
Exelixis, Inc. (Nasdaq: EXEL) today reported encouraging data from an ongoing Phase 1 dose-escalation trial of XL228 in patients with advanced malignancies. XL228 is a small molecule inhibitor of insulin-like growth factor type 1 receptor (IGF1R), SRC, Aurora kinases, and fibroblast growth factor receptor types 1, 2, and 3 (FGFR1-3), which are associated with cancer cell proliferation, survival, and metastasis. The compound also inhibits BCR-ABL, including the T315I mutant form which is resistant to currently approved inhibitors. David Smith, MD, Professor of Medicine at the University of Michigan, an investigator on the Phase 1 trial, will present the data in an oral session (Abstract #3512) beginning at 4:15 p.m. local time on Saturday, May 30, 2009, at the American Society of Clinical Oncology Annual Meeting, which is being held May 29-June 2 in Orlando.
Medical Devices

Judge To Hear Arguments On S.D. Abortion Law Requiring Statement That Procedure Ends Human Life

A federal judge will hear oral arguments on July 17 regarding a lawsuit challenging a South Dakota law that requires doctors to tell women seeking abortions that the procedure will end a human life, the AP/Sioux City Journal reports. Planned Parenthood, which operates the state"s only abortion clinic, appealed the law after it was passed in 2005. U.S. District Judge Karen Schreier temporarily prevented the law from going into effect, but the 8th U.S. Circuit Court of Appeals in July 2008 overruled that order, and the state began enforcing the law. According to the AP/Journal, Schreier will decide during the hearing whether to grant motions for summary judgment and will consider Planned Parenthood"s request to stop the state from imposing sanctions over the law"s requirements (AP/Sioux City Journal, 6/26). Reprinted with kind permission from http://www.nationalpartnership.org. You can view the entire Daily Women"s Health Policy Report, search the archives, or sign up for email delivery here. The Daily Women"s Health Policy Report is a free service of the National Partnership for Women & Families, published by The Advisory Board Company. © 2009 The Advisory Board Company. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):